| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 1451 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 668* | 2021 |
| The ongoing challenge of latent tuberculosis H Esmail, CE Barry 3rd, DB Young, RJ Wilkinson Philosophical Transactions of the Royal Society B: Biological Sciences 369 …, 2014 | 408 | 2014 |
| Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis BM Mayosi, M Ntsekhe, J Bosch, S Pandie, H Jung, F Gumedze, J Pogue, ... New England Journal of Medicine 371 (12), 1121-1130, 2014 | 299 | 2014 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 218 | 2022 |
| Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, AK Coussens, ... Nature medicine 22 (10), 1090-1093, 2016 | 184 | 2016 |
| Subclinical tuberculosis disease—a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology B Frascella, AS Richards, B Sossen, JC Emery, A Odone, I Law, I Onozaki, ... Clinical Infectious Diseases 73 (3), e830-e841, 2021 | 183 | 2021 |
| Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial BP Ndiaye, F Thienemann, M Ota, BS Landry, M Camara, S Dièye, ... The Lancet Respiratory Medicine 3 (3), 190-200, 2015 | 162 | 2015 |
| Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis RK Gupta, CT Turner, C Venturini, H Esmail, MX Rangaka, A Copas, ... The Lancet Respiratory Medicine 8 (4), 395-406, 2020 | 146 | 2020 |
| Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies H Esmail, CE Barry III, RJ Wilkinson Drug discovery today 17 (9-10), 514-521, 2012 | 128 | 2012 |
| Tuberculosis infectiousness and host susceptibility RD Turner, C Chiu, GJ Churchyard, H Esmail, DM Lewinsohn, NR Gandhi, ... The Journal of infectious diseases 216 (suppl_6), S636-S643, 2017 | 119 | 2017 |
| The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons H Esmail, C Riou, E du Bruyn, RPJ Lai, YXR Harley, G Meintjes, ... Annual review of immunology 36, 603-638, 2018 | 118 | 2018 |
| Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis H Esmail, RP Lai, M Lesosky, KA Wilkinson, CM Graham, S Horswell, ... Proceedings of the National Academy of Sciences 115 (5), E964-E973, 2018 | 97 | 2018 |
| The wonder years: what can primary school children teach us about immunity to Mycobacterium tuberculosis? JA Seddon, SS Chiang, H Esmail, AK Coussens Frontiers in immunology 9, 414598, 2018 | 81 | 2018 |
| Tuberculosis is changing TM Walker, ALG Cruz, TE Peto, EG Smith, H Esmail, DW Crook The Lancet Infectious Diseases 17 (4), 359-361, 2017 | 61 | 2017 |
| Detection and treatment of subclinical tuberculosis BD Robertson, D Altmann, C Barry, B Bishai, S Cole, T Dick, K Duncan, ... Tuberculosis 92 (6), 447-452, 2012 | 50 | 2012 |
| From latent to patent: rethinking prediction of tuberculosis F Cobelens, S Kik, H Esmail, DM Cirillo, C Lienhardt, A Matteelli The Lancet Respiratory Medicine 5 (4), 243-244, 2017 | 39 | 2017 |
| Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations H Esmail, F Cobelens, D Goletti European Respiratory Journal 55 (3), 2020 | 38 | 2020 |
| Tuberculosis transmission during the subclinical period: could unrelated cough play a part? H Esmail, PJ Dodd, RMGJ Houben The lancet Respiratory medicine 6 (4), 244-246, 2018 | 38 | 2018 |
| Mind the gap–managing tuberculosis across the disease spectrum H Esmail, L Macpherson, AK Coussens, RMGJ Houben EBioMedicine 78, 2022 | 31 | 2022 |
Ruth R MillerCanexia HealthVerified email at canexiahealth.com
